4.7 Article

Genetic polymorphisms in DNA repair and oxidative stress pathways associated with malignant melanoma susceptibility

期刊

EUROPEAN JOURNAL OF CANCER
卷 47, 期 17, 页码 2618-2625

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.ejca.2011.05.011

关键词

DNA repair; Oxidative stress; Polymorphism; Melanoma; Susceptibility

类别

资金

  1. Ministerio de Salud Carlos III (ISCIII) [FI10-00405]
  2. Spanish Ministerio de Educacion y Ciencia under FPI [BES-2008009234]
  3. Ministerio de Salud Carlos III [CP08-00069]

向作者/读者索取更多资源

Background: Base excision repair (BER) and nucleotide excision repair (NER) pathways eliminate a wide variety of DNA damage, including UV photoproducts. The ability of each individual to repair DNA damage following different causes might explain at least in part the variability in cancer susceptibility. Moreover, inflammatory response to UV exposure may further contribute to skin carcinogenesis by oxidative stress mechanisms. Single nucleotide polymorphisms in genes encoding various DNA-repair enzymes and oxidative stress factors may be candidate low-penetrance variants with a role in susceptibility to different cancers, particularly in those with aetiologies linked to environmental exposure, such as malignant melanoma (MM). Methods: In this case control study, 684 Spanish sporadic MM patients and 406 cancer-free control subjects were included and the role of 46 polymorphisms belonging to 16 BER and NER genes as well as 11 genes involved in oxidative stress processes were investigated. Results: One polymorphism was identified to be individually associated with MM in the Spanish population. The variant was found in the NOS1 oxidative stress gene (rs2682826; p-value = 0.01). These results suggest a putative role of oxidative stress processes in the genetic predisposition to melanoma. Conclusion: To the authors' knowledge, this is the largest DNA repair-related SNP study in melanoma risk conducted in the Spanish population up to now. Furthermore, it also represents a comprehensive genetic study of several oxidative stress polymorphisms tested in relation to MM susceptibility. (C) 2011 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

CSVS, a crowdsourcing database of the Spanish population genetic variability

Maria Pena-Chilet, Gema Roldan, Javier Perez-Florido, Francisco M. Ortuno, Rosario Carmona, Virginia Aquino, Daniel Lopez-Lopez, Carlos Loucera, Jose L. Fernandez-Rueda, Asuncion Gallego, Francisco Garcia-Garcia, Anna Gonzalez-Neira, Guillermo Pita, Rocio Nunez-Torres, Javier Santoyo-Lopez, Carmen Ayuso, Pablo Minguez, Almudena Avila-Fernandez, Marta Corton, Miguel Angel Moreno-Pelayo, Matias Morin, Alvaro Gallego-Martinez, Jose A. Lopez-Escamez, Salud Borrego, Guillermo Antinolo, Jorge Amigo, Josefa Salgado-Garrido, Sara Pasalodos-Sanchez, Beatriz Morte, Angel Carracedo, Angel Alonso, Joaquin Dopazo

Summary: The Collaborative Spanish Variability Server (CSVS) is a database containing genomes and exomes of unrelated Spanish individuals, generated through a crowdsourcing effort. It provides data support for studying disease variants and population genetic variations, with a web interface for querying and conducting pseudo-control studies for diseases.

NUCLEIC ACIDS RESEARCH (2021)

Review Oncology

Circulating Tumor DNA Detection by Digital-Droplet PCR in Pancreatic Ductal Adenocarcinoma: A Systematic Review

Marisol Huerta, Susana Rosello, Luis Sabater, Ana Ferrer, Noelia Tarazona, Desamparados Roda, Valentina Gambardella, Clara Alfaro-Cervello, Marina Garces-Albir, Andres Cervantes, Maider Ibarrola-Villava

Summary: Pancreatic cancer is a highly challenging and poor prognosis malignancy. Liquid biopsy using circulating tumor DNA (ctDNA) shows great potential as a non-invasive biomarker for early diagnosis, prognosis, and management of the disease, although its sensitivity remains limited and cannot be used as a screening or diagnostic tool.

CANCERS (2021)

Article Oncology

Metabolic Health Together with a Lipid Genetic Risk Score Predicts Survival of Small Cell Lung Cancer Patients

Lara P. Fernandez, Maria Merino, Gonzalo Colmenarejo, Juan Moreno Rubio, Tais Gonzalez Pessolani, Guillermo Reglero, Enrique Casado, Maria Sereno, Ana Ramirez de Molina

Summary: Despite advancements in surgery and therapies, small cell lung cancer (SCLC) remains one of the deadliest types of cancer. A metabolic precision approach for SCLC patients is proposed for the first time, highlighting the importance of metabolic health and lipid gene expression in predicting SCLC survival. Two lipid metabolism genes, racemase and perilipin 1, along with a genetic risk score of both genes, are shown to be biomarkers of SCLC survival. Importantly, controlling metabolic health, lipid gene expression, and lifestyle-associated environmental factors is crucial for increased SCLC survival.

CANCERS (2021)

Article Biochemistry & Molecular Biology

Discovering potential interactions between rare diseases and COVID-19 by combining mechanistic models of viral infection with statistical modeling

Macarena Lopez-Sanchez, Carlos Loucera, Maria Pena-Chilet, Joaquin Dopazo

Summary: Recent studies have shown the importance of host genetics in the prognosis of COVID-19. This study used a mathematical mechanistic model to identify potential interactions between rare disease genes and the COVID-19 infection process. Out of the analyzed disease genes, 254 genes directly affect the COVID-19 molecular disease mechanism and 207 genes have an indirect effect. These findings suggest the potential for preventive measures in some rare diseases based on the links between disease genes and COVID-19 hallmarks.

HUMAN MOLECULAR GENETICS (2022)

Article Multidisciplinary Sciences

Towards a metagenomics machine learning interpretable model for understanding the transition from adenoma to colorectal cancer

Carlos S. Casimiro-Soriguer, Carlos Loucera, Maria Pena-Chilet, Joaquin Dopazo

Summary: The gut microbiome has gained attention for its association with diseases like colorectal cancer and its potential to predict diseases through non-intrusive biomarkers. A meta-analysis of fecal metagenomic samples revealed that an interpretable machine learning approach based on functional profiles showed greater accuracy in predicting colorectal cancer compared to previous proposals. This approach was also effective in identifying samples with adenoma, making it promising for detecting early stages of colorectal cancer and facilitating intervention. Functional profiles provide insights into the molecular mechanisms behind these conditions and have demonstrated superior accuracy compared to taxonomic profiles.

SCIENTIFIC REPORTS (2022)

Article Oncology

GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases

Fernando Pereira, Angel Serrano, Israel Manzanedo, Estibalitz Perez-Viejo, Santiago Gonzalez-Moreno, Luis Gonzalez-Bayon, Alvaro Arjona-Sanchez, Juan Torres, Isabel Ramos, Maria E. Barrios, Pedro Cascales, Rafael Morales, Enrique Boldo, Alfonso Garcia-Fadrique, Xabier Arteaga, Alberto Gutierrez-Calvo, Susana Sanchez-Garcia, Enrique Asensio, Cesar P. Ramirez, Manuel Artiles, Javier Vaque, Pedro A. Parra, Pedro Villarejo, Cristobal Munoz-Casares, Estrella Turienzo, Alicia Calero, Isabel Jaen Torrejimeno, Isabel Prieto, Julio Galindo, Vicente Borrego, Manuel E. Marcello, Cristina Rihuete, Joaquin Carrasco, Luis Gomez-Quiles

Summary: The French PRODIGE 7 trial raised doubts about the specific survival benefit of HIPEC with oxaliplatin for colorectal cancer peritoneal metastases. The GECOP-MMC trial aims to evaluate the effectiveness of HIPEC with high-dose mytomicin-C in preventing peritoneal recurrence in limited peritoneal metastasis from colon cancer. The primary endpoint is 3-year peritoneal recurrence-free survival.

BMC CANCER (2022)

Meeting Abstract Clinical Neurology

MUTATIONAL LANDSCAPE OF RISK VARIANTS IN DEPRESSION AND OBESITY RELATED-GENES: A NEXT GENERATION SEQUENCING APPROACH

Ana M. Perez-Gutierrez, Rosario Carmona, Luis Javier Martinez-Gonzalez, Elena Lopez-Isac, Joaquin Dopazo, Jorge A. Cervilla, Blanca Gutierrez, Esther Molina, Juan Antonio Zarza-Rebollo, Maria Pena-Chilet, Daniel Lopez-Lopez, Javier Perez-Florido, Margarita Rivera

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2022)

Article Oncology

Correlation between BAP1 Localization, Driver Mutations, and Patient Survival in Uveal Melanoma

Yasemin C. Cole, Yu-Zhi Zhang, Beatrice Gallo, Adam P. Januszewski, Anca Nastase, David J. Essex, Caroline M. H. Thaung, Victoria M. L. Cohen, Mandeep S. Sagoo, Anne M. Bowcock

Summary: A study on 100 uveal melanomas from the UK revealed that loss of nuclear BAP1 (nBAP1) predicts shorter overall survival. Tumors with BAP1 loss of function mutations frequently exhibited heterogeneous BAP1 staining, and tumors with >= 25% loss of nBAP1 were a more reliable prognostic indicator than chromosome 3 loss (LOH3) or chromosome 8q gain. Majority of BAP1 mutations result in loss of nBAP1 and aberrant expression of cBAP1.

CANCERS (2022)

Article Biochemistry & Molecular Biology

An SPM-Enriched Marine Oil Supplement Shifted Microglia Polarization toward M2, Ameliorating Retinal Degeneration in rd10 Mice

Lorena Olivares-Gonzalez, Sheyla Velasco, Idoia Gallego, Marina Esteban-Medina, Gustavo Puras, Carlos Loucera, Alicia Martinez-Romero, Maria Pena-Chilet, Jose Luis Pedraz, Regina Rodrigo

Summary: This study evaluated the effect of an essential fatty acid (EFA) supplement containing specialized pro-resolving mediators (SPMs) on retinal degeneration and microglia activation in a mouse model of RP. The EFA supplement improved retinal function, reduced inflammation and microglia activation, and reduced oxidative stress markers. These findings suggest that oral supplementation with SPMs such as the EFA supplement could be a potential therapeutic approach for resolving inflammation in RP.

ANTIOXIDANTS (2023)

Article Biochemistry & Molecular Biology

Crosstalk between Metabolite Production and Signaling Activity in Breast Cancer

Cankut Cubuk, Carlos Loucera, Maria Pena-Chilet, Joaquin Dopazo

Summary: Reprogramming metabolism is a key feature of cancer, and recent research suggests that metabolites may play a crucial role in regulating signaling pathways. Mechanistic models were used to analyze the metabolic and signaling pathway activities of Breast invasive Carcinoma (BRCA), and Gaussian Processes combined with SHapley Additive exPlanations (SHAP) were employed to identify potential causal relationships between metabolite production and signaling pathway regulation. A total of 317 metabolites were found to significantly impact signaling circuits, revealing a complex crosstalk between signaling and metabolic pathways.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Pharmacology & Pharmacy

A Comprehensive Analysis of 21 Actionable Pharmacogenes in the Spanish Population: From Genetic Characterisation to Clinical Impact

Rocio Nunez-Torres, Guillermo Pita, Maria Pena-Chilet, Daniel Lopez-Lopez, Jorge Zamora, Gema Roldan, Belen Herraez, Nuria Alvarez, Maria Rosario Alonso, Joaquin Dopazo, Anna Gonzalez-Neira

Summary: The implementation of pharmacogenetics (PGx) is a significant milestone for achieving safer and more effective therapies in precision medicine. However, the adoption of PGx diagnostics is slow and unequal worldwide, partly due to the lack of ethnic-specific PGx information. Genetic data from 3006 Spanish individuals were analyzed, revealing allele frequencies and putative deleterious variants for main PGx genes. A comparison of high-throughput diagnostic techniques indicated that genotyping with the PGx HT array is the most suitable solution. The integrated information is made available through the Collaborative Spanish Variant Server for the scientific community.

PHARMACEUTICS (2023)

Review Biology

Neural Stem Cells as Potential Glioblastoma Cells of Origin

Alba Loras, Luis G. Gonzalez-Bonet, Julia L. Gutierrez-Arroyo, Conrado Martinez-Cadenas, Maria Angeles Marques-Torrejon

Summary: Glioblastoma multiforme (GBM) is an incurable and highly malignant brain tumor in adults. It contains a cell population called glioma stem cells (GSCs) that contribute to therapy resistance and tumor recurrence. Recent data suggest that neural stem cells (NSCs) in the subventricular zone (SVZ) may be the cells of origin for GBM and are also involved in disease progression and recurrence. Identifying the cellular origin of GBM is crucial for early detection techniques and the development of targeted therapies.

LIFE-BASEL (2023)

Article Virology

Real-world evidence with a retrospective cohort of 15,968 COVID-19 hospitalized patients suggests 21 new effective treatments

Carlos Loucera, Rosario Carmona, Marina Esteban-Medina, Gerrit Bostelmann, Dolores Munoyerro-Muniz, Roman Villegas, Maria Pena-Chilet, Joaquin Dopazo

Summary: This study utilized data from the Andalusian Population Health Database to investigate the relationship between prior drug consumption and patient outcomes in COVID-19. It identified 21 drugs associated with better patient survival and effectively controlled covariates.

VIROLOGY JOURNAL (2023)

Article Genetics & Heredity

A crowdsourcing database for the copy-number variation of the Spanish population

Daniel Lopez-Lopez, Gema Roldan, Jose Fernandez-Rueda, Gerrit Bostelmann, Rosario Carmona, Virginia Aquino, Javier Perez-Florido, Francisco Ortuno, Guillermo Pita, Rocio Nunez-Torres, Anna Gonzalez-Neira, Maria Pena-Chilet, Joaquin Dopazo

Summary: SPACNACS is a collaborative database that collects copy number variation data from more than 400 genomes and exomes of unrelated Spanish individuals. It provides detailed information on the local genetic variability and can be used for disease gene discovery and pharmacogenomics research.

HUMAN GENOMICS (2023)

Article Biotechnology & Applied Microbiology

Folliculin-interacting protein FNIP2 impacts on overweight and obesity through a polymorphism in a conserved 3′ untranslated region

Lara P. Fernandez, Nerea Deleyto-Seldas, Gonzalo Colmenarejo, Alba Sanz, Sonia Wagner, Ana Belen Plata-Gomez, Monica Gomez-Patino, Susana Molina, Isabel Espinosa-Salinas, Elena Aguilar-Aguilar, Sagrario Ortega, Osvaldo Grana-Castro, Viviana Loria-Kohen, Pablo J. Fernandez-Marcos, Alejo Efeyan, Ana Ramirez de Molina

Summary: This study identified a SNP, rs2291007, in the conserved region of the 3'UTR of the FNIP2 gene that is associated with multiple leanness parameters. The SNP affects FNIP2 mRNA levels and leads to decreased adiposity and increased leanness in both human volunteers and mice. FNIP2 expression is an important contributor to body mass index prediction.

GENOME BIOLOGY (2022)

Article Oncology

Genomic profiling of tissue and blood predicts survival outcomes in patients with resected pleural mesothelioma

Diego de Miguel-Perez, Edward M. Pickering, Umberto Malapelle, William Grier, Francesco Pepe, Pasquale Pisapia, Gianluca Russo, Joseph A. Pinto, Alessandro Russo, Giancarlo Troncone, Melissa J. Culligan, Katherine A. Scilla, Ranee Mehra, Pranshu Mohindra, Oscar Arrieta, Andres F. Cardona, Marzia Del Re, Ashutosh Sachdeva, Fred R. Hirsch, Andrea Wolf, Joseph S. Friedberg, Christian Rolfo

Summary: In this study, genetic alterations in resectable pleural mesothelioma tissues and blood samples were analyzed, and it was found that high tissue tumor mutational burden, tissue median minor allele frequency, blood tumor mutational burden, and specific mutations were correlated with outcomes in patients with resected PM. These findings suggest that molecular profiling could help identify longer survivors in patients with resected PM.

EUROPEAN JOURNAL OF CANCER (2024)

Article Oncology

Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trial

Davide Melisi, Camilla Zecchetto, Valeria Merz, Giuseppe Malleo, Luca Landoni, Alberto Quinzii, Simona Casalino, Federica Fazzini, Marina Gaule, Camilla Pesoni, Luca Casetti, Alessandro Esposito, Giovanni Marchegiani, Cristiana Piazzola, Mirko D'Onofrio, Riccardo de Robertis, Armando Gabbrielli, Laura Bernardoni, Stefano F. Crino, Silvia Pietrobono, Claudio Luchini, Camillo Aliberti, Guido Martignoni, Stefano Milleri, Giovanni Butturini, Aldo Scarpa, Roberto Salvia, Claudio Bassi

Summary: This study evaluated the safety and activity of liposomal irinotecan in the perioperative treatment of resectable pancreatic ductal adenocarcinoma (rPDAC) patients. The results showed that NALIRIFOX has manageable and active outcomes, and should be further investigated in randomized trials comparing it to standard upfront surgery followed by adjuvant therapy.

EUROPEAN JOURNAL OF CANCER (2024)

Article Oncology

Phase I LITESPARK-001 study of belzutifan for advanced solid tumors: Extended 41-month follow-up in the clear cell renal cell carcinoma cohort

Eric Jonasch, Todd M. Bauer, Kyriakos P. Papadopoulos, Elizabeth R. Plimack, Jaime R. Merchan, David F. Mcdermott, M. Dror Michaelson, Leonard J. Appleman, Ananya Roy, Rodolfo F. Perini, Yanfang Liu, Toni K. Choueiri

Summary: After a median follow-up of 41.2 months, belzutifan monotherapy demonstrated durable antitumor activity in patients with advanced ccRCC and acceptable safety.

EUROPEAN JOURNAL OF CANCER (2024)

Article Oncology

Impact of colorectal cancer screening on survival after metachronous metastasis

Patricia A. H. Hamers, Geraldine R. Vink, Marloes A. G. Elferink, Leon M. G. Moons, Cornelis J. A. Punt, Anne M. May, Miriam Koopman

Summary: Screen-detection of the primary tumor is associated with longer overall survival after metachronous metastasis.

EUROPEAN JOURNAL OF CANCER (2024)

Article Oncology

Sentinel-node biopsy in apparent early stage ovarian cancer: final results of a prospective multicentre study (SELLY)

Camilla Nero, Nicolo Bizzarri, Stefano Di Berardino, Francesca Sillano, Giuseppe Vizzielli, Francesco Cosentino, Virginia Vargiu, Pierandrea De Iaco, Anna Myriam Perrone, Enrico Vizza, Benito Chiofalo, Stefano Uccella, Fabio Ghezzi, Luigi Carlo Turco, Giacomo Corrado, Diana Giannarelli, Tina Pasciuto, Gian Franco Zannoni, Anna Fagotti, Giovanni Scambia

Summary: This study evaluates the sensitivity and specificity of sentinel-lymph-node mapping compared to systematic lymphadenectomy in detecting lymph node metastasis in early stage ovarian cancer. The results show that sentinel-lymph-node mapping did not reach the expected sensitivity, but ultra-staging protocol improved the accuracy of diagnosis for patients.

EUROPEAN JOURNAL OF CANCER (2024)

Article Oncology

The features and management of acquired resistance to PD1-based therapy in metastatic melanoma

Adriana Hepner, Judith M. Versluis, Roslyn Wallace, Clara Allayous, Lauren Julia Brown, Claudia Trojanielloh, Camille Lea Gerardi, Yanina J. L. Jansenj, Prachi Bhave, Bart Neyns, Andrew Haydon, Olivier Michielin, Joanna Manganan Oliver Klein, Alexander N. Shoushtari, Allison Betof Warner, Paolo Antonio Ascierto, Jennifer Leigh McQuade, Matteo S. Carlino, Lisa Zimmer, Celeste Lebbe, Douglas B. Johnson, Shahneen Sandhu, Victoria Atkinson, Christian U. Blank, Serigne N. Lo, Georgina V. Long, Alexander M. Menzies

Summary: Acquired resistance to PD-1 therapy in melanoma is mainly oligometastatic, and patients may have a favorable survival outcome following salvage treatment.

EUROPEAN JOURNAL OF CANCER (2024)

Article Oncology

Major cardiovascular adverse events in older adults with early-stage triple-negative breast cancer treated with adjuvant taxane plus anthracycline versus taxane-based chemotherapy regimens: A SEER-medicare study

Savannah Roy, Stephanie Lakritz, Anna R. Schreiber, Elizabeth Molina Kuna, Cathy J. Bradley, Lavanya Kondapalli, Jennifer R. Diamond

Summary: This study evaluates major adverse cardiovascular events (MACE) in older women with TNBC treated with anthracycline and taxane-based chemotherapy (ATAX) compared to taxane-based chemotherapy (TAX). The results show that ATAX does not increase the risk of MACE and there is no difference in survival between patients who received TAX and ATAX.

EUROPEAN JOURNAL OF CANCER (2024)

Letter Oncology

Osimertinib-induced urticarial vasculitis in a patient with lung cancer: A rare cutaneous toxicity

Pei-Chun Weng, Yau-Li Huang, Chun-Yu Cheng

EUROPEAN JOURNAL OF CANCER (2024)

Article Oncology

Deep learning based histological classification of adnex tumors

Philipp Jansen, Jean Le 'Clerc Arrastia, Daniel Otero Baguer, Maximilian Schmidt, Jennifer Landsberg, Joerg Wenzel, Michael Emberger, Dirk Schadendorf, Eva Hadaschik, Peter Maass, Klaus Georg Griewank

Summary: This study highlights the enormous potential of artificial intelligence in pathology, showing that it can aid in the identification of rare cutaneous adnexal tumors and potentially become a standard tool in routine diagnostics.

EUROPEAN JOURNAL OF CANCER (2024)

Article Oncology

FOLFIRINOX chemotherapy modulates the peripheral immune landscape in pancreatic cancer: Implications for combination therapies and early response prediction

Casper W. F. van Eijck, Gaby Strijk, Eveline E. Vietscha, Fleur van der Sijde, Maaike Verheij, Dana A. M. Mustafa, Madelief Vinkc, Joachim G. J. V. Aerts, Casper H. J. van Eijck, Marcella Willemsen

Summary: The study reveals that FOLFIRINOX has immunomodulatory effects, suggesting its potential in immune-based combination therapies for pancreatic cancer. Additionally, certain plasma proteins hold promise as circulating predictive biomarkers for early prediction of FOLFIRINOX response in patients with pancreatic cancer.

EUROPEAN JOURNAL OF CANCER (2024)

Article Oncology

Immunotherapy response in microsatellite stable metastatic colorectal cancer is influenced by site of metastases

Marwan Fakih, Chongkai Wang, Jaideep Sandhu, Jian Ye, Colt Egelston, Xiaochen Li

Summary: This study explores the impact of metastatic sites on treatment outcomes for chemotherapy-refractory colorectal cancer patients. It found that patients with liver or peritoneal metastases had poor treatment outcomes, while those with lung-only metastases showed significant response. The presence of concurrent lymph node or other extrahepatic metastatic disease diminished treatment response in patients with lung metastases. Future checkpoint inhibitor trials should stratify patients based on metastatic locations.

EUROPEAN JOURNAL OF CANCER (2024)

Article Oncology

Peptide absent sequences emerging in human cancers

Georgios Christos Tsiatsianis, Candace S. Y. Chan, Ioannis Mouratidis, Nikol Chantzi, Anna Maria Tsiatsiani, Nelson S. Yee, Apostolos Zaravinos, Verena Kantere, Ilias Georgakopoulos-Soares

Summary: The study reveals that nullpeptides can serve as biomarkers for cancer detection and treatment, particularly in highly recurrent cancer patients. These nullpeptides primarily occur in highly expressed genes, particularly in specific loci of oncogenes and tumor suppressors. Recurrent nullpeptides are more likely to be found in neoantigens, which play a significant role in immunotherapy.

EUROPEAN JOURNAL OF CANCER (2024)